Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Bilateral risk for subsequent breast cancer estimated
October 20th, 2005
Scientists performed bilateral risk assessment for subsequent breast cancer after diagnosis of lobular carcinoma-in-situ (LCIS). "Noninvasive lesions involving the lobules of the breast are increasingly diagnosed as incidental microscopic findings at the time of lumpectomy or core-needle biopsy. We investigated the incidence rates of invasive breast cancer (IBC) after a diagnosis of LCIS by using Surveillance, Epidemiology, and End Results (SEER) data. Patients (N=4,853) having a diagnosis of primary LCIS in the time period of 1973 to 1998 were identified using the SEER Public Use CD-ROM data," scientists in the United States reported. "The database...
Source: Women's Health Weekly (2005-10-20)
|
